News
A second-generation anti-CD40 therapy that inhibits B- and T-cell activity nearly eliminated multiple sclerosis activity over ...
8d
Medindia on MSNWorld Multiple Sclerosis Day: Voices of Strength, Stories of HopeMultiple Sclerosis affects millions worldwide with diverse symptoms; early diagnosis, multidisciplinary care, and awareness ...
Fenebrutinib helped patients with relapsing forms of MS remain nearly free of relapses and disability progression up to two years, data show.
Though some cancer patients lack sufficient enzymes to metabolize capecitabine or 5-FU, many patients are not warned about the risks associated with these treatments.
Most people who drink coffee appreciate the quick jolt of energy it provides. But in a new study, presented today at the ...
Roche has shared long-term phase 2 data on its BTK inhibitor fenebrutinib in relapsing multiple sclerosis (MS), | Roche has shared long-term phase 2 data on its BTK inhibitor fenebrutinib in relapsing ...
2d
Verywell Health on MSNWhat Happens to Your Body When You Add Zinc to Your DietZinc is an essential nutrient with many health benefits. Learn about zinc's health benefits, food sources, safety concerns, ...
Medical pros revisit the 150-year history of coffee enemas to weigh their potential benefits and hidden dangers.
Australian prosecutors claim Erin Patterson invited the guests to lunch and served them Beef Wellington laced with death cap ...
Discover how neurodegenerative diseases may start with blood-brain barrier damage, leading to memory loss and cognitive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results